Media Library
icon
-
ImagelockLocations / ImageView from Kleinbasel towards Novartis Campus Basel
View from Kleinbasel towards Novartis Campus Basel
-
ImagelockLocations / ImageBird's eye view, Novartis Pavillon
Bird's eye view, Novartis Pavillon
-
ImagelockLocations / ImageMain entrance, Novartis Pavillon
Main entrance, Novartis Pavillon
-
ImagelockLeadership / ImageJohn D. Young
Member of the Board of Directors since March 7, 2023
-
PDFlockPublications / ReportNovartis in Society Integrierter Geschäftsbericht 2022
The Novartis in Society Integrated Report covers our business, strategy and performance. It highlights progress against our ESG targets and describes how we create value for diverse stakeholders. This is the German version of the report.
-
ImagelockLocations / ImageManufacturing RNA therapies in Schweizerhalle, Switzerland
Manufacturing RNA therapies in Schweizerhalle, Switzerland
-
ImagelockLocations / ImageView of RNA production in Schweizerhalle, Switzerland
View of RNA production in Schweizerhalle, Switzerland
-
ImagelockLocations / ImageProduction process of RNA therapies in Schweizerhalle, Switzerland
Production process of RNA therapies in Schweizerhalle, Switzerland
-
PDFlockFact Sheet52-week results for Cosentyx® in hidradenitis suppurativa: A summary
Discover the data published in The Lancet on the long-term effect of Cosentyx® (secukinumab) in adults with hidradenitis suppurativa from the SUNRISE and SUNSHINE trials.
-
PDFlockPublications / ReportNovartis in Society Integrated Report 2022
The Novartis in Society Integrated Report covers our business, strategy and performance. It highlights progress against our ESG targets and describes how we create value for diverse stakeholders.
-
PDFlockPublications / ReportNovartis Annual Report 2022
This report, filed with the SIX Swiss Exchange in Switzerland, provides a comprehensive overview of Novartis, including our company structure, corporate governance and compensation practices. It also discloses our operating and financial results, accompanied by audited annual financial statements.
-
ImagelockMalaria Initiative / InfographicHow Novartis is contributing to the fight against malaria
The global malaria burden and the achievements Novartis accomplished in the fight against it to date.
Pagination
- ‹ Previous page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- …
- 25
- › Next page